Healthcare >> CEO Interviews >> October 12, 2001
JEAN-JACQUES BIENAIME was elected Chairman in October 2000. Before
joining SangStat as President and COO in 1998 and then CEO in 1999, Mr.
Bienaime was Senior Vice-President of Corporate Marketing and Business
Development at Rhne Poulenc Rorer Inc., now Aventis. Since 1992 he held
various positions of increasing responsibility within RPR's US and
International marketing, sales and corporate strategy department,
including full P&L responsibility for a 650 person US organization with
revenues of over $400 million. Previously at Genentech, Mr. Bienaime was
responsible for launching Activase', one of the most successful
biotechnology drug launches in the United States. Mr. Bienaime received
his Masters of Business Administration from the Wharton School at the
University of Pennsylvania and a degree in Economics from Ecole
Superieure de Commerce de Paris in France. He is a member of the Board
of Directors of Aerogen Inc. and of Fox Chase Cancer Center in
Philadelphia. Profile
should be aware of?
Mr. Bienaime: Sangstat has been making very significant progress in
terms of revenues of existing
